The pharmacology of prodrugs of 5-fluorouracil and 1-beta-D-arabinofuranosylcytosine.
D000215:Acylation; D003504:Ancitabine / Q000031:analogs & derivatives / Q000494:pharmacology; D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage; D002626:Chemistry, Pharmaceutical; D003561:Cytarabine / Q000031:analogs & derivatives / Q000494:pharmacology*; D005467:Floxuridine / Q000494:pharmacology; D005472:Fluorouracil / Q000031:analogs & derivatives / Q000494:pharmacology*; D006801:Humans; D010743:Phospholipids; D011743:Pyrimidines; D013256:Steroids; D005641:Tegafur / Q000494:pharmacology
D000970:Antineoplastic Agents; D010743:Phospholipids; D011743:Pyrimidines; D013256:Steroids; D005467:Floxuridine; D003561:Cytarabine; D005641:Tegafur; D003504:Ancitabine; D005472:Fluorouracil